Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts
- PMID: 34003984
- PMCID: PMC8039573
- DOI: 10.1167/tvst.10.4.6
Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts
Abstract
Purpose: The purpose of this study was to present the effects of the prostanoid EP2 agonist, omidenepag (OMD) on human orbital fibroblasts (HOFs) using a three-dimension (3D) cell culture.
Methods: During adipogenesis of 3D HOFs organoids, changes in size, lipids staining, mRNA expression of adipogenesis related genes, PPARγ, AP2, and ADIPOQ, and extracellular matrix, collagen 1 (COL 1), COL 4, COL 6, and fibronectin (FN), and stiffness by a micro-squeezer were examined in the presence and absence of either 100 nM bimatoprost acid (BIM-A) or 10, 100, or 10,000 nM OMD.
Results: The size of the 3D organoids increased dramatically during adipogenesis, and these were further enhanced in the presence of OMD in contrast to the BIM-A induced suppression effect. The intensity of lipid staining and the mRNA expression of PPARγ were significantly increased upon adipogenesis, and both or latter was markedly inhibited in the presence of OMD or BIM-A, respectively. AP2 expression was also upregulated by adipogenesis, and was further enhanced by BIM-A. The adipogenesis-induced downregulation of COL 1 and FN, or the upregulation of the expression of COL 4 and COL 6 were all suppressed in the presence of BIM-A. In contrast, OMD caused similar effects on COL 4, COL 6, or FN expression, but caused a significant increase in COL 1 expression. Stiffness was significantly increased upon adipogenesis, and was further increased or substantially decreased by BIM-A or OMD, respectively.
Conclusions: The present study indicates that the FP2 agonist, OMD, had different effects on 3D HOFs organoids, as compared to BIM-A.
Translational relevance: The current study suggests that OMD may not induce deepening of upper eyelid sulcus (DUES).
Conflict of interest statement
Disclosure:
Figures




Similar articles
-
Prostaglandin F2α and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts.Exp Eye Res. 2021 Apr;205:108489. doi: 10.1016/j.exer.2021.108489. Epub 2021 Feb 12. Exp Eye Res. 2021. PMID: 33587909
-
Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids.Prostaglandins Leukot Essent Fatty Acids. 2021 Aug;171:102315. doi: 10.1016/j.plefa.2021.102315. Epub 2021 Jul 3. Prostaglandins Leukot Essent Fatty Acids. 2021. PMID: 34246925
-
Simultaneous Use of ROCK Inhibitors and EP2 Agonists Induces Unexpected Effects on Adipogenesis and the Physical Properties of 3T3-L1 Preadipocytes.Int J Mol Sci. 2021 Apr 28;22(9):4648. doi: 10.3390/ijms22094648. Int J Mol Sci. 2021. PMID: 33925005 Free PMC article.
-
Addition of ROCK inhibitors to prostaglandin derivative (PG) synergistically affects adipogenesis of the 3D spheroids of human orbital fibroblasts (HOFs).Hum Cell. 2022 Jan;35(1):125-132. doi: 10.1007/s13577-021-00623-y. Epub 2021 Sep 30. Hum Cell. 2022. PMID: 34591280
-
Simultaneous Effects of a Selective EP2 Agonist, Omidenepag, and a Rho-Associated Coiled-Coil Containing Protein Kinase Inhibitor, Ripasudil, on Human Orbital Fibroblasts.J Ocul Pharmacol Ther. 2023 Sep;39(7):439-448. doi: 10.1089/jop.2023.0025. Epub 2023 Jun 23. J Ocul Pharmacol Ther. 2023. PMID: 37352418
Cited by
-
Application of Single Cell Type-Derived Spheroids Generated by Using a Hanging Drop Culture Technique in Various In Vitro Disease Models: A Narrow Review.Cells. 2024 Sep 14;13(18):1549. doi: 10.3390/cells13181549. Cells. 2024. PMID: 39329734 Free PMC article. Review.
-
Benzalkonium Chloride, Even at Low Concentrations, Deteriorates Intracellular Metabolic Capacity in Human Conjunctival Fibroblasts.Biomedicines. 2022 Sep 18;10(9):2315. doi: 10.3390/biomedicines10092315. Biomedicines. 2022. PMID: 36140416 Free PMC article.
-
Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension.Clin Ophthalmol. 2022 Apr 26;16:1261-1279. doi: 10.2147/OPTH.S340386. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35510270 Free PMC article. Review.
-
Effect of Prostaglandin E2 Agonist Omidenepag on the Expression of Matrix Metalloproteinase in Trabecular Meshwork Cells.Korean J Ophthalmol. 2022 Apr;36(2):123-130. doi: 10.3341/kjo.2021.0169. Epub 2022 Jan 24. Korean J Ophthalmol. 2022. PMID: 35067026 Free PMC article.
-
From Eye Care to Hair Growth: Bimatoprost.Pharmaceuticals (Basel). 2024 Apr 27;17(5):561. doi: 10.3390/ph17050561. Pharmaceuticals (Basel). 2024. PMID: 38794131 Free PMC article. Review.
References
-
- Fuwa M, Toris CB, Fan S, et al. .. Effects of a novel selective EP2 receptor agonist, omidenepag isopropyl, on aqueous humor dynamics in laser-induced ocular hypertensive monkeys. J Ocul Pharmacol Ther. 2018; 34: 531–537. - PubMed
-
- Kirihara T, Taniguchi T, Yamamura K, et al. .. Pharmacologic characterization of omidenepag isopropyl, a novel selective EP2 receptor agonist, as an ocular hypotensive agent. Invest Ophthalmol Vis Sci. 2018; 59: 145–153. - PubMed
-
- Cheema A, Chang RT, Shrivastava A, Singh K.. Update on the medical treatment of primary open-angle glaucoma. Asia Pac J Ophthalmol (Phila). 2016; 5: 51–58. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous